Zai Lab President & COO Josh Smiley Departs; CEO Samantha Du Absorbs Responsibilities
ZLAB sits 20% above its 52-week low of $15.96.
Summary
Zai Lab announced the departure of its President and Chief Operating Officer, Josh Smiley, with CEO Samantha Du and other management absorbing his responsibilities.
Key Events · Executive and Board Changes · ZLAB
-
President & COO Departs
Josh Smiley ceased serving as President and Chief Operating Officer of Zai Lab, effective May 18, 2026, with his last day of employment being May 22, 2026.
-
Responsibilities Absorbed by CEO
The responsibilities previously associated with these positions have been assumed by Samantha Du, the Company's Board Chair, Founder, and Chief Executive Officer, and other members of the management team.
-
Severance Agreement
Mr. Smiley will receive severance pursuant to his existing employment agreement, subject to his execution of a customary release.
Analysis · ZLAB · Life Sciences
The departure of a key C-suite executive like the President and Chief Operating Officer can raise concerns about leadership stability and operational continuity, especially as responsibilities are being absorbed by the CEO and other management rather than an immediate replacement. This event adds to recent negative signals, including a Q1 revenue decrease and ongoing insider share sales.
At the time of this filing, ZLAB was trading at $19.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $15.96 to $44.34. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.